Top segments and regional performance

Last year, the company generated ‪43.23 B‬ CHF, the most of which — ‪13.98 B‬ CHF — came from its top-performing segment, Oncology, compared to ‪12.98 B‬ CHF the previous year. The greatest contribution came from United States, which accounted for ‪19.38 B‬ CHF last year, with ‪18.62 B‬ CHF the year before.